Genus (LON:GNS) Announces Earnings Results

Genus (LON:GNS - Get Free Report) posted its quarterly earnings results on Thursday. The company reported GBX 110.30 earnings per share (EPS) for the quarter, Digital Look Earnings reports. Genus had a net margin of 7.07% and a return on equity of 9.70%.

Here are the key takeaways from Genus' conference call:

• FY 2026 results were strong: adjusted profit before tax and adjusted EPS each rose 35%, while free cash flow increased to £62 million and leverage fell to 0.4x.
• Genus announced a £60 million share buyback for FY 2027 and recommended a 10% increase in the full-year dividend to 35.2 pence per share, reflecting confidence in cash generation and future growth.
• PIC delivered broad-based growth, including 52% royalty-revenue growth in China and market-share gains, while the new China joint venture is expected to support further expansion in the world’s largest porcine market.
• PRP regulatory progress continued with approvals or favorable determinations in Argentina, Canada, Uruguay, and Peru; commercialization is now beginning in selected Latin American markets, although approvals in Mexico and China remain pending.
• Management expects FY 2027 underlying adjusted profit before tax to be only moderately higher, with growth weighted toward the second half due to weak agricultural markets, North American disease pressures, lower Brazilian growth, depressed dairy conditions, and higher PRP and product-development costs.

Genus Stock Down 5.9%

LON GNS opened at GBX 2,102 on Thursday. The business has a fifty day moving average price of GBX 2,223.11 and a 200 day moving average price of GBX 2,382.24. The company has a debt-to-equity ratio of 51.73, a quick ratio of 1.08 and a current ratio of 2.25. The company has a market cap of £1.40 billion, a P/E ratio of 29.61, a P/E/G ratio of 2.87 and a beta of 0.90. Genus has a one year low of GBX 1,943 and a one year high of GBX 3,220.

Wall Street Analyst Weigh In

Separately, Berenberg Bank reissued a "buy" rating and issued a GBX 3,350 price objective on shares of Genus in a report on Thursday. Three equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the company currently has a consensus rating of "Buy" and a consensus price target of GBX 3,216.67.

Insider Buying and Selling at Genus

In other Genus news, insider Celia Baxter acquired 2,336 shares of the company's stock in a transaction that occurred on Friday, June 26th. The stock was bought at an average price of GBX 2,140 per share, with a total value of £49,990.40. Corporate insiders own 0.71% of the company's stock.

About Genus

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands.